BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
44.86
-0.26 (-0.58%)
At close: Jun 27, 2025, 4:00 PM
44.79
-0.07 (-0.16%)
After-hours: Jun 27, 2025, 6:55 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $8.52 billion as of June 27, 2025. Its market cap has increased by 63.56% in one year.
Market Cap
8.52B
Enterprise Value
9.84B
1-Year Change
63.56%
Ranking
Category
Stock Price
$44.86
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $8.52B, an increase of 156.59%. That is a compound annual growth rate of 17.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 701.76B |
| Johnson & Johnson | 365.60B |
| AbbVie | 328.48B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 273.08B |
| Abbott Laboratories | 241.38B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |